Study guide

7.2 Prescription Content & Validity Requirements

Minnesota MPJE Pharmacy Jurisprudence

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy

2 Federal Controlled Substances Foundations

2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss

3 Federal Drug Regulation, Privacy & Supply Chain

3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity

4 MN Board, Licensure & Eligibility

4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience

5 Renewal, CE, PIC & Discipline

5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting

6 Technicians, Interns & Supervision

6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy

7 Prescription Authority & Validity

7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits

8 Advanced MN Pharmacist Practice

8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management

9 Counseling, DUR & Patient Safety

9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)

10 MN PMP & Opioid Public-Health Laws

10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags

11 Dispensing: Transfers, Labels & Substitution

11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine

12 Pharmacy Operations & Facilities

12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation

13 Compounding & Hazardous Drugs

13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates

14 Test-Day Strategy & Final Review

14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps

7.2 Prescription Content & Validity Requirements

Key Takeaways Explain This Topic AI

§151.01, subd. 16a requires date, patient name/address, drug/quantity, directions, practitioner name/address, and a reachable practitioner phone number

Paper/fax prescriptions need a manual signature; electronic prescriptions need an electronic signature

Controlled-substance orders must also meet Minn. Stat. §152.11 and federal CSA/EPCS content and transmission rules

Non-CS prescriptions need not bear a DEA number (§152.11, subd. 2a); CS pickup generally requires photo ID unless the purchaser is known (§152.11, subd. 2d)

Complete content does not cure out-of-scope practice, failed examination validity, or lack of legitimate medical purpose

Last updated: July 2026

7.2 Prescription Content & Validity Requirements

Quick Answer: A valid prescription under Minn. Stat. §151.01, subd. 16a is a written/printed, oral-reduced-to-writing, or electronic prescription drug order issued for an individual patient by a practitioner in the scope and usual course of practice. Required elements include date of issue , patient name and address , drug name and quantity , directions for use , practitioner name and address , and a telephone number where the practitioner can be reached. Paper/fax orders need the practitioner’s manual signature ; electronic orders need an electronic signature . Controlled-substance orders must also meet §152.11 and federal CSA content rules. Pharmacists must not dispense invalid orders under §151.37 .

If section 7.1 answers who may prescribe, this section answers what the order must contain to be a lawful prescription drug order.

Prescription Drug Order vs Prescription

§151.01, subd. 16 defines a prescription drug order as a lawful written, oral, or electronic order of a practitioner for a drug for a specific patient . Controlled-substance orders must also satisfy §152.11 and the federal Controlled Substances Act and regulations.

§151.01, subd. 16a then defines prescription as a prescription drug order that is:

  • Written or printed on paper,
  • An oral order reduced to writing by a pharmacist, or
  • An electronic order

To be valid , the prescription must:

  • Be issued for an individual patient
  • Be issued by a practitioner within the scope and usual course of the practitioner’s practice
  • Contain the required data elements listed below
  • Bear the correct form of signature for the transmission method

A chart order ( subd. 16b ) is a specialized inpatient/LTC facility order for drugs dispensed by a pharmacist (or intern under direct supervision) and administered only during the stay; it has its own element list (patient name, another identifier, drug, directions, signature). Do not force community outpatient Rx rules onto every hospital chart order—and do not ignore chart-order signature timing rules on institutional items.

Required Content Elements — §151.01, subd. 16a

Minnesota’s outpatient prescription must include:

  • Element Why it matters on the MPJE
  • Date of issue Starts the clock for fill/refill windows (including MN 12-month rule)
  • Patient name and address Identifies the specific patient; missing address is a common defect
  • Name and quantity of the drug Defines what and how much may be dispensed
  • Directions for use Legal labeling and counseling baseline
  • Practitioner name and address Identifies the lawful prescriber
  • Telephone number where the practitioner can be reached Verification pathway for the pharmacy
  • Signature rules

Written or printed on paper given to the patient/agent, or transmitted by fax : must contain the practitioner’s manual signature

Electronic prescription : must contain the practitioner’s electronic signature ( §151.01, subd. 32 defines electronic signature)

Exam trap: accepting an unsigned fax “for convenience” or an electronic transmission that is really an insecure email without a compliant electronic signature.

Controlled-Substance Content Overlay — §152.11 + Federal Rules

For Schedules II–V, Minnesota §152.11, subd. 1 voids a written or oral-reduced CS prescription unless it:

  • Is written in ink and contains the name and address of the person for whose use it is intended
  • States the amount of the controlled substance with directions for use

For written prescriptions: includes the prescriber’s handwritten signature , address , federal registry (DEA) number , and a designation of the branch of the healing art ; for oral prescriptions: name and address of the prescriber and branch of healing art

Shows the date signed by the prescriber (or date of pharmacy acceptance if oral)

Electronic CS prescriptions must comply with §62J.497 standards and the federal EPCS portions of 21 CFR parts 1300, 1304, 1306, and 1311. Faxed CS prescriptions must meet 21 CFR part 1306 requirements applicable to facsimile transmission.

DEA number on non-CS prescriptions

§152.11, subd. 2a states a prescription need not bear a DEA number if the drug is not a Schedule II–V controlled substance, and no person shall impose a requirement inconsistent with this subdivision . Do not demand a DEA number for ordinary legend drugs (or for gabapentin reporting contexts that use other identifiers)—the statute forbids that practice.

Photo ID at pickup for CS

§152.11, subd. 2d requires the person purchasing a Schedule II–V controlled substance to present valid photographic identification , unless the purchaser is known to the dispenser . Veterinary dispensers must also comply. This is a dispensing-time validity control, not a substitute for prescription content.

Oral and Fax Orders

Oral orders : lawful when the practitioner type and drug class allow them; the pharmacist reduces the order to writing with required elements. Emergency oral CII authority is federal/Minnesota emergency-limited (see section 7.3)—not a routine path for convenience.

Fax : paper-like signature rules apply for non-electronic fax of written orders; CS fax validity depends on federal schedule-specific fax rules (for example, CII fax is limited to listed exceptions such as hospice/LTCF/compounded injectable contexts under federal law).

Incomplete, Ambiguous, or Altered Orders

A prescription missing a required element is not “close enough.” Pharmacist options:

  • Clarify with the prescriber and document the clarification (who, when, what changed)
  • Refuse to dispense until the defect is cured
  • Never invent missing quantities, directions, or signatures

Alterations, different inks, mismatched patient names, or photocopied signatures are classic invalidity or forgery red flags. Corresponding responsibility (especially for CS) requires you to resolve legitimacy concerns, not paper over them.

Validity Beyond Content: Purpose and Exam Rules

Even a perfectly completed form is invalid if:

  • The prescriber is outside scope/course of practice
  • The order fails §151.37, subd. 2(d) examination requirements for listed high-risk drugs
  • The CS order lacks legitimate medical purpose under federal 21 CFR 1306.04
  • The transmission method is unlawful for that schedule

Content compliance is necessary but not sufficient.

Record Retention Snapshot

Minnesota §152.11 requires pharmacies to retain original CS prescriptions (including electronic/fax originals retrievable as transmitted) for not less than two years , open to inspection. Align this with federal two-year CS record retention; if any Minnesota operational rule is stricter in a vignette, follow the stricter path.

Practical Outpatient Checklist

Before first fill, confirm:

  • Practitioner is a Minnesota-recognized prescriber for this drug
  • Patient name and address present
  • Drug name, strength/form, and quantity clear
  • Directions usable for labeling
  • Date of issue present and not stale under fill rules
  • Practitioner name, address, and phone present
  • Correct manual or electronic signature for the modality
  • If CS: DEA number, schedule-appropriate transmission, photo-ID plan at pickup
  • If high-risk drug under §151.37(d): examination-based validity not obviously absent
  • Common Exam Traps
  • Omitting patient address or prescriber phone as “optional”
  • Treating a stamped signature as a valid manual signature on a paper Rx
  • Requiring DEA numbers on pure non-CS legend prescriptions contrary to §152.11, subd. 2a
  • Filling a CS fax that federal rules do not authorize for that schedule/setting
  • Confusing chart orders with community outpatient prescriptions
  • Study Checklist
  • List all §151.01, subd. 16a elements from memory
  • Separate manual vs electronic signature rules
  • Add §152.11 CS extras (DEA number, branch of healing art, ink/handwritten rules)
  • Apply photo-ID rule at CS pickup
  • State that content completeness does not cure lack of legitimate purpose or exam-based invalidity

Master content rules so you can spot a defective order in one pass under exam timing pressure.